Australia's largest stock trading and investment forum Australia's #1 stock forum

GMV

0.00%

3.9¢ g medical innovations holdings limited

Ann: Appendix 4C - quarterly, page-69

First 69 Last

Share
Profile

Follow
axbci

669 Posts.

325

03/08/18

10:50

Post #: 34704468
Share

Originally posted by Ruby15 ↑

Hi Idisley,

I must confess that my patience has been tested and still is, however I have been reassured with one of the previous threads which showed the presence of GMV within the India region. The fact that work is still being conducted behind the scenes is reassurance personified.

I still cannot comprehend how this SP is so low considering the enormous potential of this company. It is almost like the SP is being manipulated to the downside but for what reason. Its not like shares are being snapped up, its quite the opposite. The SP is stagnated with trades barely keeping the price ticking over.

I feel it in my bones that Aug is going to be a good month for GMV. The green channel process if you look at the dates, indicates that the approval could be as early as 6 Aug with a further month before complete approval is granted. I would love for the CFDA and Factory be given approval concurrently which would allow the 1 billion + in MOU's to commence.

All in all, the GMV family on Hotcopper need to remain strong and see this process through until the end.
The upside for this stock is ginormous and I remain totally committed and faithful to Dr G and his team.

Cheers Rubes

Expand

Hope you're right mate. When we start seeing some increased movement in volume i think we'll be very close to CFDA.

GMV Price at posting: 19.0¢ Sentiment: Hold Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

BUX

Buxton projects new graphite province discovery at WA Narryer play

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

There are more pages in this discussion • 1 more message in this thread...

First 69 Last

Add GMV (ASX) to my watchlist

Ann: Appendix 4C - quarterly, page-69

Top Stories

BCI reaches close of funding facility for salt-first part of Mardie project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Buxton projects new graphite province discovery at WA Narryer play

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Featured News